Go Pro
NASDAQ:AIMD

Ainos (AIMD) Stock Price, News & Analysis

Ainos logo
$1.39 -0.02 (-1.28%)
As of 12:58 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Ainos Stock (NASDAQ:AIMD)

Advanced

Key Stats

Today's Range
$1.35
$1.46
50-Day Range
$1.31
$2.74
52-Week Range
$1.26
$4.50
Volume
13,831 shs
Average Volume
449,743 shs
Market Capitalization
$11.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Ainos, Inc. (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format. AI‐401 is engineered to target airway inflammation in conditions such as cystic fibrosis and other chronic respiratory diseases. In preclinical studies, the formulation demonstrated favorable pulmonary deposition and sustained release, and it has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of cystic fibrosis.

In addition to AI‐401, Ainos is exploring the application of its dry powder inhalation technology for other anti‐inflammatory and anti‐infective agents, with the goal of expanding its pipeline into multiple respiratory indications. The company collaborates with contract development and manufacturing organizations (CDMOs) to advance product candidates through formulation optimization, toxicology assessments and early clinical trials.

Founded in the United States, Ainos is headquartered in Philadelphia and serves patients and healthcare providers primarily in North America and Europe. The company’s management team comprises executives with extensive experience in respiratory drug development, regulatory affairs and commercial strategy. Ainos aims to leverage its inhalation platform to bring novel pulmonary therapies to market and address unmet medical needs in chronic lung disease.

AI Generated. May Contain Errors.

Ainos Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
8th Percentile Overall Score

AIMD MarketRank™: 

Ainos scored higher than 8% of companies evaluated by MarketBeat, and ranked 551st out of 593 stocks in the technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Ainos has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Ainos has only been the subject of 1 research reports in the past 90 days.

  • Read more about Ainos' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Ainos is -0.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Ainos is -0.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Ainos has a P/B Ratio of 1.07. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.18% of the float of Ainos has been sold short.
  • Short Interest Ratio / Days to Cover

    Ainos has a short interest ratio ("days to cover") of 0.22, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Ainos has recently increased by 0.55%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Ainos does not currently pay a dividend.

  • Dividend Growth

    Ainos does not have a long track record of dividend growth.

  • News Sentiment

    Ainos has a news sentiment score of -0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Technology companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Ainos this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Ainos insiders have sold 2,227.48% more of their company's stock than they have bought. Specifically, they have bought $15,435.00 in company stock and sold $359,247.00 in company stock.

  • Percentage Held by Insiders

    9.79% of the stock of Ainos is held by insiders.

  • Percentage Held by Institutions

    Ainos has minimal institutional ownership at this time.

  • Read more about Ainos' insider trading history.
Receive AIMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ainos and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AIMD Stock News Headlines

Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel
Ainos Sinks on Release of New Article
AIMD Using AI Technology to Advance Semi Manufacturing
See More Headlines

AIMD Stock Analysis - Frequently Asked Questions

Ainos' stock was trading at $1.64 at the start of the year. Since then, AIMD stock has decreased by 15.9% and is now trading at $1.38.

Ainos, Inc. (NASDAQ:AIMD) released its quarterly earnings data on Monday, August, 3rd. The company reported ($0.62) EPS for the quarter. The company earned $0.15 million during the quarter. Ainos had a negative trailing twelve-month return on equity of 186.12% and a negative net margin of 11,912.10%.

Shares of Ainos reverse split before market open on Thursday, December 14th 2023.The 1-5 reverse split was announced on Thursday, December 14th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Ainos (AIMD) raised $3 million in an initial public offering (IPO) on Tuesday, August 9th 2022. The company issued 800,000 shares at a price of $4.25 per share. Maxim Group served as the underwriter for the IPO and Brookline Capital Markets was co-manager.

Shares of AIMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ainos investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), e.l.f. Beauty (ELF), Disc Medicine (IRON), Jabil (JBL) and Adobe (ADBE).

Company Calendar

Last Earnings
8/03/2026
Today
8/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Technology Hardware, Storage & Peripherals
Sub-Industry
Technology Hardware, Storage & Peripherals
Current Symbol
NASDAQ:AIMD
Previous Symbol
NASDAQ:AIMD
CIK
1014763
Employees
40
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.89)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.77 million
Net Margins
-11,912.10%
Pretax Margin
-77,466.66%
Return on Equity
-186.12%
Return on Assets
-66.07%

Debt

Debt-to-Equity Ratio
1.58
Current Ratio
0.55
Quick Ratio
0.50

Sales & Book Value

Annual Sales
$120 thousand
Price / Sales
96.99
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.29 per share
Price / Book
1.06

Miscellaneous

Outstanding Shares
8,520,000
Free Float
7,690,000
Market Cap
$11.64 million
Optionable
Not Optionable
Beta
2.46
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:AIMD) was last updated on 8/5/2026 by MarketBeat.com Staff.
From Our Partners